Compare ISPC & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ISPC | POAS |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.9M |
| IPO Year | 2020 | 2024 |
| Metric | ISPC | POAS |
|---|---|---|
| Price | $0.92 | $2.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 104.7K | ★ 203.9K |
| Earning Date | 11-16-2026 | 11-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,928,998.00 | N/A |
| Revenue This Year | $638.10 | N/A |
| Revenue Next Year | $17.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $0.13 |
| 52 Week High | $115.00 | $7.40 |
| Indicator | ISPC | POAS |
|---|---|---|
| Relative Strength Index (RSI) | 23.43 | 85.55 |
| Support Level | N/A | $0.23 |
| Resistance Level | $1.15 | $2.83 |
| Average True Range (ATR) | 0.07 | 0.23 |
| MACD | 0.00 | 0.26 |
| Stochastic Oscillator | 2.94 | 80.78 |
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers high tech microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.